Continue Reading Below
Shares of plant biotechnology company, 22nd Century Group, Inc. (NYSEMKT: XXII) hit a new 52-week high Friday, gaining 12.1% as of 3:52 p.m. EDT. Recently presented results from a big clinical trial suggest the company's patented tobacco technology helps smokers drop the habit.
Although the details of the 1,250-patient study are still under peer review, preliminary results from the University of Pittsburgh sponsored study bode well for 22nd Century Group. The lead investigator stated that smokers whose nicotine intake was immediately reduced by switching to cigarettes filled with the company's very low nicotine (VLN) tobacco had a better chance of rapidly quitting than smokers who were gradually weaned off the addictive substance.
Friday's announcement comes at a good time for 22nd Century Group. Earlier this year, recently appointed Food and Drug Administration (FDA) Commissioner Scott Gottlieb promised to finally flex the regulatory muscle congress enacted about eight years ago. 22nd Century Group claims it's the only company capable of supplying America's $130 billion industry with VLN tobacco.
Continue Reading Below
It's important to note, 22nd Century Group didn't release any data from the study. We don't know how many patients given VLN cigarettes ceased smoking permanently, or if there was a statistically significant difference between the groups.
While Friday's announcement does little to improve the company's outlook, becoming the U.S. tobacco industry's exclusive supplier of cigarette tobacco would expand the company's recent $357 million market cap many times over. The FDA hasn't given any timing details regarding a possible VLN cigarette mandate, and none of the industry heavyweights have signed any big contracts yet. Until they do, investors better stay braced for volatility.
10 stocks we like better than 22nd Century Group
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and 22nd Century Group wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of September 5, 2017